Vertex Reports Third-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Vertex (VRTX) PT Lowered to $204 at RBC Capital
October 25, 2018 7:43 AM EDTRBC Capital analyst Brian Abrahams lowered the price target on Vertex (NASDAQ: VRTX) to $204.00 (from $208.00) while maintaining a Outperform rating.
... MoreVertex Pharma (VRTX) Tops Q3 EPS by 7c
October 24, 2018 4:02 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.09, $0.07 better than the analyst estimate of $1.02. Revenue for the quarter came in at $783.9 million versus the consensus estimate of $790.91 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
... More